A cluster randomized trial of interferon ß-1a for the reduction of transmission of SARS-Cov-2: protocol for the Containing Coronavirus Disease 19 trial (ConCorD-19).

Carolina IturriagaNat EifflerRad AnibaRym Ben-OthmanGuillermo Perez-MatelunaJessica K V MeyerEleanor N FishTobias R KollmannNicolas SeverinoStephen StickArturo BorzutzkyCecilia PerretJosé A Castro-RodriguezDiego García-Huidobro

Published in: BMC infectious diseases (2021)

This trial is registered at ClinicalTrials.gov NCT04552379; date of registration September 17, 2020.

Keyphrases

sars cov
coronavirus disease
phase iii
study protocol
phase ii
respiratory syndrome coronavirus
clinical trial
randomized controlled trial
open label
double blind